<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on 4 April 2026 at 05:14 by All in One SEO v4.9.3 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://new-medicines.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>NEW MEDICINES</title>
		<link><![CDATA[https://new-medicines.com]]></link>
		<description><![CDATA[NEW MEDICINES]]></description>
		<lastBuildDate><![CDATA[Thu, 22 Feb 2024 10:31:51 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://new-medicines.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://new-medicines.com/donanemab-a-promising-d/]]></guid>
			<link><![CDATA[https://new-medicines.com/donanemab-a-promising-d/]]></link>
			<title>Donanemab: A New Drug for Dementia</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 10:31:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/atzumi/]]></guid>
			<link><![CDATA[https://new-medicines.com/atzumi/]]></link>
			<title>Atzumi: The Nasal Powder Revolutionizing Migraine Treatment</title>
			<pubDate><![CDATA[Sun, 11 May 2025 09:17:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/truqap-capivasertib-a-new-drug-approved-by-the-fda-for-breast-cancer-costs-24146-for-64-tablets/]]></guid>
			<link><![CDATA[https://new-medicines.com/truqap-capivasertib-a-new-drug-approved-by-the-fda-for-breast-cancer-costs-24146-for-64-tablets/]]></link>
			<title>Truqap (Capivasertib) a New Drug Approved by the FDA for Breast Cancer, Costs $24,146 for 64 tablets</title>
			<pubDate><![CDATA[Wed, 10 Jul 2024 11:20:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/about/]]></guid>
			<link><![CDATA[https://new-medicines.com/about/]]></link>
			<title>About</title>
			<pubDate><![CDATA[Wed, 10 Apr 2024 09:16:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/omvoh/]]></guid>
			<link><![CDATA[https://new-medicines.com/omvoh/]]></link>
			<title>Omvoh (Mirikizumab): A New Treatment for Inflammatory Bowel Disease</title>
			<pubDate><![CDATA[Tue, 21 Jan 2025 08:17:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/vyvanse/]]></guid>
			<link><![CDATA[https://new-medicines.com/vyvanse/]]></link>
			<title>Understanding Vyvanse: Benefits, Side Effects, Usage Guidelines and Shortage</title>
			<pubDate><![CDATA[Tue, 12 Mar 2024 12:05:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/semaglutide-clinical-trials/]]></guid>
			<link><![CDATA[https://new-medicines.com/semaglutide-clinical-trials/]]></link>
			<title>Clinical Trials on Semaglutide in 2024</title>
			<pubDate><![CDATA[Sat, 30 Mar 2024 09:10:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/wegovy-news/]]></guid>
			<link><![CDATA[https://new-medicines.com/wegovy-news/]]></link>
			<title>Wegovy News and Updates</title>
			<pubDate><![CDATA[Sat, 30 Mar 2024 08:51:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/wegovy-long-term-impact/]]></guid>
			<link><![CDATA[https://new-medicines.com/wegovy-long-term-impact/]]></link>
			<title>The Long-Term Impact of Wegovy on Weight Loss: A Look at the SELECT Trial</title>
			<pubDate><![CDATA[Sat, 25 May 2024 09:42:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/wegovy-for-weight-loss/]]></guid>
			<link><![CDATA[https://new-medicines.com/wegovy-for-weight-loss/]]></link>
			<title>Weight Loss: Wegovy received FDA approval but be careful of side effects</title>
			<pubDate><![CDATA[Sat, 23 Mar 2024 00:56:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/adhd-trials-2024/]]></guid>
			<link><![CDATA[https://new-medicines.com/adhd-trials-2024/]]></link>
			<title>Clinical Trials for ADHD Treatments in 2024</title>
			<pubDate><![CDATA[Mon, 22 Apr 2024 10:16:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/clinical-trials-weight-loss-2024/]]></guid>
			<link><![CDATA[https://new-medicines.com/clinical-trials-weight-loss-2024/]]></link>
			<title>Current Clinical Trials on Weight Loss in Progress: A 2024 Overview</title>
			<pubDate><![CDATA[Mon, 08 Apr 2024 01:07:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/karxt/]]></guid>
			<link><![CDATA[https://new-medicines.com/karxt/]]></link>
			<title>A New Schizophrenia Treatment: KarXT</title>
			<pubDate><![CDATA[Fri, 21 Jun 2024 11:04:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/wegovy-price-guide/]]></guid>
			<link><![CDATA[https://new-medicines.com/wegovy-price-guide/]]></link>
			<title>Wegovy Price Guide</title>
			<pubDate><![CDATA[Sun, 17 Mar 2024 02:21:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/wegovy/]]></guid>
			<link><![CDATA[https://new-medicines.com/wegovy/]]></link>
			<title>Wegovy: Availability, Shortage and Side Effects</title>
			<pubDate><![CDATA[Sun, 17 Mar 2024 01:59:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/ozempic-shortage/]]></guid>
			<link><![CDATA[https://new-medicines.com/ozempic-shortage/]]></link>
			<title>Ozempic Shortage 2024: Impact and Alternatives in the Pharmaceutical Market</title>
			<pubDate><![CDATA[Sun, 10 Mar 2024 12:51:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/alvotech-a-fda-approval/]]></guid>
			<link><![CDATA[https://new-medicines.com/alvotech-a-fda-approval/]]></link>
			<title>Alvotech (ALVO) and FDA Approval for ATV02: Investing Opportunity</title>
			<pubDate><![CDATA[Sun, 10 Mar 2024 12:43:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/fda-approved-pills/]]></guid>
			<link><![CDATA[https://new-medicines.com/fda-approved-pills/]]></link>
			<title>A Comprehensive Guide to FDA Approved Birth Control Pills and their Cost</title>
			<pubDate><![CDATA[Thu, 07 Mar 2024 12:25:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/investing-in-the-pharmaceutical-stocks/]]></guid>
			<link><![CDATA[https://new-medicines.com/investing-in-the-pharmaceutical-stocks/]]></link>
			<title>Why Should You Consider Investing in the Pharmaceutical Stock Market?</title>
			<pubDate><![CDATA[Thu, 07 Mar 2024 12:14:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/investing-in-covid-19-vaccine/]]></guid>
			<link><![CDATA[https://new-medicines.com/investing-in-covid-19-vaccine/]]></link>
			<title>Vaccine Bubble Burst: Why Investing in COVID-19 Manufacturers May No Longer Be the Shot in the Arm</title>
			<pubDate><![CDATA[Thu, 07 Mar 2024 12:06:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/fidanacogene-elaparvovec/]]></guid>
			<link><![CDATA[https://new-medicines.com/fidanacogene-elaparvovec/]]></link>
			<title>Fidanacogene Elaparvovec: A Breakthrough in Hemophilia B Treatment</title>
			<pubDate><![CDATA[Thu, 07 Mar 2024 12:06:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/avt02-adalimumab/]]></guid>
			<link><![CDATA[https://new-medicines.com/avt02-adalimumab/]]></link>
			<title>AVT02: A Promising Biosimilar Drug to Adalimumab (Humira)</title>
			<pubDate><![CDATA[Thu, 07 Mar 2024 12:01:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/wagovy_pharma_stocks/]]></guid>
			<link><![CDATA[https://new-medicines.com/wagovy_pharma_stocks/]]></link>
			<title>Wegovy: Financial Impact, Revenue and Stock Price Analysis</title>
			<pubDate><![CDATA[Sun, 10 Mar 2024 02:08:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/litfulo-ritlecitinib/]]></guid>
			<link><![CDATA[https://new-medicines.com/litfulo-ritlecitinib/]]></link>
			<title>Litfulo (Ritlecitinib): A New Medicine for Hair Loss</title>
			<pubDate><![CDATA[Sat, 17 Aug 2024 10:55:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/terms-and-conditions/]]></guid>
			<link><![CDATA[https://new-medicines.com/terms-and-conditions/]]></link>
			<title>Terms and Conditions</title>
			<pubDate><![CDATA[Thu, 29 Feb 2024 23:52:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/sotatercept/]]></guid>
			<link><![CDATA[https://new-medicines.com/sotatercept/]]></link>
			<title>Sotatercept for Pulmonary Arterial Hypertension</title>
			<pubDate><![CDATA[Thu, 29 Feb 2024 04:39:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/opt-out-preferences/]]></guid>
			<link><![CDATA[https://new-medicines.com/opt-out-preferences/]]></link>
			<title>Opt-out preferences</title>
			<pubDate><![CDATA[Thu, 29 Feb 2024 02:43:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/gene-therapy/]]></guid>
			<link><![CDATA[https://new-medicines.com/gene-therapy/]]></link>
			<title>Gene Therapy: A Game-Changer in Medicine</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 11:23:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/from-lab-to-market-the-journey-of-a-new-drug/]]></guid>
			<link><![CDATA[https://new-medicines.com/from-lab-to-market-the-journey-of-a-new-drug/]]></link>
			<title>From Lab to Market: The Journey of a New Drug</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 11:10:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/the-impact-of-new-drug-discoveries-on-the-pharma-stock-market/]]></guid>
			<link><![CDATA[https://new-medicines.com/the-impact-of-new-drug-discoveries-on-the-pharma-stock-market/]]></link>
			<title>The Impact of New Drug Discoveries on the Pharma Stock Market</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 11:07:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/blinatumomab-blina-revolutionizing-cancer-treatment/]]></guid>
			<link><![CDATA[https://new-medicines.com/blinatumomab-blina-revolutionizing-cancer-treatment/]]></link>
			<title>Blinatumomab (Blina): Revolutionizing Cancer Treatment</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 11:01:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/how-to-invest-in-pharmaceutical-companies/]]></guid>
			<link><![CDATA[https://new-medicines.com/how-to-invest-in-pharmaceutical-companies/]]></link>
			<title>How to invest in pharmaceutical companies?</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 10:38:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/keen-an-eye-on-minerva-nasdaq-nerv-new-drug-for-schizophrenia-under-review-in-february-2024/]]></guid>
			<link><![CDATA[https://new-medicines.com/keen-an-eye-on-minerva-nasdaq-nerv-new-drug-for-schizophrenia-under-review-in-february-2024/]]></link>
			<title>Minerva (NASDAQ: NERV): New Drug For Schizophrenia Under Review In February 2024</title>
			<pubDate><![CDATA[Thu, 22 Feb 2024 10:33:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/contact/]]></guid>
			<link><![CDATA[https://new-medicines.com/contact/]]></link>
			<title>Contact</title>
			<pubDate><![CDATA[Sun, 03 Mar 2024 11:57:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://new-medicines.com/privacy-policy/]]></guid>
			<link><![CDATA[https://new-medicines.com/privacy-policy/]]></link>
			<title>Privacy Policy</title>
			<pubDate><![CDATA[Mon, 26 Feb 2024 11:08:58 +0000]]></pubDate>
		</item>
				</channel>
</rss>
